Always easiest to say nothing when there's nothing to say. Investor presentation dated 16/09/20 "GeneType Breast Cancer and Colorectal tests are in market with anticipatedrelease of Cardiovascular and T2D tests in Q3 CY20" Clearly cardiovascular and Type 2 diabetes tests are another missed timeline.
- Forums
- ASX - By Stock
- GTG
- The vast majority of the world(90%) remains at risk..
The vast majority of the world(90%) remains at risk.., page-20
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.671M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online